Company research
Ventas, Inc.
CIK 740260Updated Sep 24, 2026
VTR price & chart
Loading TradingView…
NYSE:VTR on TradingView ↗About the company
Ventas, Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company’s growth is fueled by its more than 850 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OITM platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas’s seasoned team of talented professionals shares a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.
In the news
No coverage from other publishers is available.
Recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 27,591,945,000Source | 26,186,906,000Source | 24,725,433,000Source | 24,157,840,000Source |
| GoodwillUSD | 1,046,072,000Source | 1,044,915,000Source | 1,045,176,000Source | 1,044,415,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 741,067,000Source | 897,850,000Source | 508,794,000Source | 122,564,000Source |
| Operating Lease, Right-of-Use AssetUSD | 295,838,000Source | 308,019,000Source | 312,142,000Source | 310,307,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 14,630,983,000Source | 15,047,081,000Source | 14,878,392,000Source | 13,671,513,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 118,732,000Source | 109,119,000Source | 100,648,000Source | 99,912,000Source |
| Retained Earnings (Accumulated Deficit)USD | -7,527,777,000Source | -6,886,653,000Source | -6,213,803,000Source | -5,449,385,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -39,851,000Source | -33,526,000Source | -35,757,000Source | -36,800,000Source |
| Stockholders' Equity Attributable to ParentUSD | 12,527,253,000Source | 10,771,267,000Source | 9,488,058,000Source | 10,152,968,000Source |
| Additional Paid in Capital, Common StockUSD | 19,976,183,000Source | 17,607,482,000Source | 15,650,734,000Source | 15,539,777,000Source |
| Liabilities and EquityUSD | 27,591,945,000Source | 26,186,906,000Source | 24,725,433,000Source | 24,157,840,000Source |
| Deferred Income Tax Liabilities, NetUSD | 23,409,000Source | 8,150,000Source | 24,500,000Source | 35,570,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 58,555,000Source | 58,329,000Source | 56,347,000Source | 68,709,000Source |
| Additional Financial Items | ||||
| AOCI, Debt Securities, Available-for-sale, Adjustment, after TaxUSD | -1,298,000Source | -2,118,000Source | -1,256,000Source | 0Source |
| Deferred Tax Liabilities, NetUSD | 20,613,000Source | 6,219,000Source | 22,746,000Source | 25,080,000Source |
| Long-term DebtUSD | 13,011,016,000Source | 13,522,551,000Source | 13,490,896,000Source | 12,296,780,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 261,518,000Source | 88,351,000Source | -30,297,000Source | -40,931,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 38,733,000Source | 30,991,000Source | 30,987,000Source | 30,715,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 1,646,726,000Source | 1,329,625,000Source | 1,119,873,000Source | 1,120,163,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -2,694,418,000Source | -2,377,089,000Source | -184,664,000Source | -859,218,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 873,757,000Source | 1,445,220,000Source | -543,749,000Source | -283,928,000Source |
| Payments of Ordinary Dividends, Common StockUSD | 860,060,000Source | 740,326,000Source | 723,559,000Source | 720,319,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | -23,214,000Source | -15,962,000Source | -8,909,000Source | -6,198,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 786,137,000Source | 957,233,000Source | 563,462,000Source | 170,745,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 579,693,000Source | 575,741,000Source | 548,108,000Source | 467,556,000Source |
| Income Taxes Paid, NetUSD | 7,314,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 2,839,000Source | -3,985,000Source | 1,257,000Source | -2,869,000Source |
| Additional Financial Items | ||||
| Amortization of Debt Issuance CostsUSD | 29,600,000Source | 28,900,000Source | 23,200,000Source | 18,200,000Source |
| Other Depreciation and AmortizationUSD | 1,379,140,000Source | 1,253,143,000Source | 1,392,461,000Source | 1,197,798,000Source |
| Equity Method Investment, Realized Gain (Loss) on DisposalUSD | — | 33,500,000Source | 33,500,000Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | -172,000Source | -687,000Source | 6,104,000Source | -581,000Source |
| General and Administrative ExpenseUSD | 177,400,000Source | 162,990,000Source | 148,876,000Source | 144,874,000Source |
| GoodwillUSD | 1,046,072,000Source | 1,044,915,000Source | 1,045,176,000Source | 1,044,415,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | — | -40,931,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | -30,297,000Source | -40,931,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | 4,468,000Source | 1,563,000Source | 13,626,000Source | 28,500,000Source |
| Income Tax Expense (Benefit)USD | -14,150,000Source | -37,775,000Source | -9,539,000Source | -16,926,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 10,137,000Source | 7,198,000Source | 10,676,000Source | 6,516,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 251,381,000Source | 81,153,000Source | -40,973,000Source | -47,447,000Source |
| Operating Lease, Lease IncomeUSD | 1,496,667,000Source | 1,496,940,000Source | 1,486,401,000Source | 1,399,313,000Source |
| Payments of Financing CostsUSD | 14,488,000Source | 35,878,000Source | 41,837,000Source | 8,824,000Source |
| Proceeds from Issuance of Common StockUSD | 2,343,687,000Source | 1,964,867,000Source | 108,455,000Source | 0Source |
| Proceeds from Noncontrolling InterestsUSD | 80,000Source | 3,703,000Source | 20,241,000Source | 5,371,000Source |
| Proceeds from Stock Options ExercisedUSD | 110,863,000Source | 26,052,000Source | 1,736,000Source | 8,691,000Source |
| Provision for Loan, Lease, and Other LossesUSD | 0Source | -166,000Source | -20,270,000Source | 19,757,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 5,833,980,000Source | 4,924,266,000Source | 4,497,827,000Source | 4,129,193,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 204,321,000Source | -7,996,000Source | -115,581,000Source | -94,137,000Source |
| Income Tax Expense (Benefit)USD | -14,150,000Source | -37,775,000Source | -9,539,000Source | -16,926,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 10,137,000Source | 7,198,000Source | 10,676,000Source | 6,516,000Source |
| Earnings Per Share, BasicUSD per share | 0.55Source | 0.2Source | -0.1Source | -0.12Source |
| Earnings Per Share, DilutedUSD per share | 0.54Source | 0.19Source | -0.1Source | -0.12Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 455,082,000Source | 411,770,000Source | 401,809,000Source | 373,368,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 462,615,000Source | 416,366,000Source | 405,670,000Source | 403,454,000Source |
| Additional Financial Items | ||||
| Business Combination, Acquisition Related CostsUSD | 10,073,000Source | 20,369,000Source | 15,215,000Source | 51,577,000Source |
| Common Stock, Dividends, Per Share, DeclaredUSD per share | 1.92Source | 1.8Source | 1.8Source | 1.8Source |
| Costs and ExpensesUSD | 5,629,659,000Source | 4,932,262,000Source | 4,613,408,000Source | 4,223,330,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 1,379,140,000Source | 1,253,143,000Source | 1,392,461,000Source | 1,197,798,000Source |
| Direct Costs of Leased and Rented Property or EquipmentUSD | 3,413,337,000Source | 2,820,562,000Source | 2,555,145,000Source | 2,276,724,000Source |
| General and Administrative ExpenseUSD | 177,400,000Source | 162,990,000Source | 148,876,000Source | 144,874,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | — | -40,931,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | -30,297,000Source | -40,931,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | 0.57Source | 0.21Source | -0.08Source | -0.1Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | 0.57Source | 0.21Source | -0.08Source | -0.1Source |
| Income (Loss) from Equity Method InvestmentsUSD | 4,468,000Source | 1,563,000Source | 13,626,000Source | 28,500,000Source |
| Interest and Other IncomeUSD | 21,010,000Source | 28,114,000Source | 11,414,000Source | 3,635,000Source |
| Interest ExpenseUSD | 612,246,000Source | 602,835,000Source | 574,112,000Source | 467,557,000Source |
| Management Fee ExpenseUSD | 224,473,000Source | 174,491,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 251,381,000Source | 81,153,000Source | -40,973,000Source | -47,447,000Source |
| Operating Lease, Lease IncomeUSD | 1,496,667,000Source | 1,496,940,000Source | 1,486,401,000Source | 1,399,313,000Source |
Filing attachments
tm2531470d1_ex99-1.htm · 8-K · 2025-11-17
EX-99.1 2 tm2531470d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Ventas Announces Planned Retirement of Peter J. Bulgarelli, EVP, Outpatient Medical & Research and CEO of Lillibridge Healthcare Services CHICAGO - November 17, 2025 - Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research and Chief Executive Officer of Lillibridge Healthcare Services, has informed the Company of his intention to retire …
Read attachment ↗tm2514732d5_ex4-2.htm · 8-K · 2025-06-03
EX-4.2 3 tm2514732d5_ex4-2.htm EXHIBIT 4.2 Exhibit 4.2 Execution Version TENTH SUPPLEMENTAL INDENTURE by and among Ventas Realty, Limited Partnership, as Issuer, Ventas, Inc., as Guarantor and U.S. Bank Trust Company, National Association, as Trustee $500,000,000 5.100% Senior Notes due 2032 Dated as of June 3, 2025 Supplement to Indenture dated as of February 23, 2018 (Senior Debt Securities) TABLE OF CONTENTS Page Article I Creation of the Securities Section 1.01. Desi…
Read attachment ↗tm2513611d1_ex99-1.htm · 8-K · 2025-04-30
EX-99.1 2 tm2513611d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Ventas, Inc. 300 North LaSalle Chicago, Illinois (877) www.ventasreit.com Street, Suite 1600 60654 4-VENTAS ───────────────────────────────────────────────────────────────────────────────────────────────────── Contact: BJ Grant (877) 4-VENTAS Ventas Reports 2025 First Quarter Results CHICAGO - Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported …
Read attachment ↗